Endpoints NewsIn final days at Merck, Roger Perlmutter bets big on a little-known Covid-19 treatmentNov 23, 2020more_vert
CNBCMerck acquires OncoImmune to ramp supply of promising Covid drugNov 23, 2020Meg TirrellBy Meg Tirrellmore_vert